Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Change in Accured Expenses (2016 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Change in Accured Expenses for 10 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 91.73% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.9 million through Dec 2025, changed 0.12% year-over-year, with the annual reading at $21.9 million for FY2025, 0.12% changed from the prior year.
  • Change in Accured Expenses for Q4 2025 was $1.3 million at Rhythm Pharmaceuticals, down from $11.0 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $15.7 million in Q4 2022, with the low at -$12.6 million in Q3 2022.
  • Average Change in Accured Expenses over 5 years is $3.9 million, with a median of $4.5 million recorded in 2023.
  • The sharpest move saw Change in Accured Expenses plummeted 309.83% in 2022, then skyrocketed 9849.06% in 2023.
  • Over 5 years, Change in Accured Expenses stood at $12.9 million in 2021, then grew by 21.61% to $15.7 million in 2022, then crashed by 69.08% to $4.9 million in 2023, then skyrocketed by 212.45% to $15.2 million in 2024, then tumbled by 91.73% to $1.3 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $1.3 million, $11.0 million, and $13.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.